Nemiralisib in Patients Experiencing an Acute Exacerbation of COPD: Design of a Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Phase IIb Study
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2019）
Key words
copd,acute exacerbation,double-blind,placebo-controlled,dose-ranging
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined